NPI | Name | Type | Address |
---|---|---|---|
DR. PHARMD Rodney Jaray Hunter |
Individual |
6400 Fannin St Ste 2900 Houston, TX |
|
PHARMD, BCOP Bryan Do |
Individual |
1515 Holcombe Blvd Unit 90 Houston, TX |
|
DR. PHARM.D. Sandra Beth Horowitz |
Individual |
1515 Holcombe Blvd Unit 377 Houston, TX |
|
RPH Adrienne Sevin |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Shilpa Paul |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Caitlin Rausch |
Individual |
1515 Holcombe Blvd # B6.4606 Houston, TX |
|
PHARMD Jenessa Lee |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Michael Frei |
Individual |
1515 Holcombe Blvd Ofc Y2.5610 Houston, TX |
|
Adam Dipippo |
Individual |
1515 Holcombe Blvd Houston, TX |
|
Alexandra Lovell |
Individual |
1515 Holcombe Blvd Ofc B6.4606 Houston, TX |
|
PHARM.D. Vananh Trinh |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Jocelyn Joseph |
Individual |
1515 Holcombe Blvd # Y2.5610 Houston, TX |
|
PHARMD Sheree Chen |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Vi Phuong Doan |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Elizabeth M Diller |
Individual |
1515 Holcombe Blvd # B6.4606 Houston, TX |
|
DR. PHARMD Laura K Whited |
Individual |
1515 Holcombe Blvd Unit 377 Houston, TX |
|
PHARMD Jennifer Lynn Zadlo |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD John Patrick Sanchez |
Individual |
1515 Holcombe Blvd Unit 90 Houston, TX |
|
Shrina Patel |
Individual |
1515 Holcombe Blvd Houston, TX |
|
PHARMD Jonathan Malara |
Individual |
1515 Holcombe Blvd Unit 37 Houston, TX |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |